Jianping Chao

Discovery of 2-Hydroxy-<i>N</i>,<i>N</i>-dimethyl-3-{2-[[(<i>R</i>)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123):  A Potent, Orally Bioavailable CXCR2/CXCR1 Receptor Antagonist

Michael P. Dwyer, Younong Yu, Jianping Chao et al. · Journal of Medicinal Chemistry · 2006 · 113 citations · Full text

Pharmaceutical Science, Drug Target, Immunology +18

Studies of thermodynamic properties of binary mixtures containing an alcohol XII. Excess molar enthalpies of an (alkan-1-ol + N, N-dimethylformamide or dimethyl sulfoxide) at 298.15 K

Jianping Chao, M. Dai, Y.X. Wang · The Journal of Chemical Thermodynamics · 1989 · 52 citations

Materials Science, Thermodynamic Modelling, Engineering +12

Octreotide-modified liposomes containing daunorubicin and dihydroartemisinin for treatment of invasive breast cancer

Rui-Jun Ju, Lan Cheng, Xiaoming Peng et al. · Artificial Cells Nanomedicine and Biotechnology · 2018 · 51 citations

Octreotide-modified Liposomes, Nanotherapeutics, Extracellular Microvesicles +24

Synthesis and structure–activity relationships of 3,4-diaminocyclobut-3-ene-1,2-dione CXCR2 antagonists

J. Robert Merritt, Laura L. Rokosz, Kingsley H. Nelson et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 46 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Medicine +4

C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists

Jianhua Chao, Arthur G. Taveras, Jianping Chao et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 43 citations · Full text

Bioavailable Cxcr2, Pharmacological Study, Biochemistry +7